Cleared Traditional

K183687 - LifeWindow LW8 Lite

K183687 is an FDA 510(k) clearance for LifeWindow LW8 Lite, manufactured by Digicare Biomedical Technology, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 271-day FDA review.

K183687 · Digicare Biomedical Technology, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2019
Decision
271d
Days
Class 2
Risk

K183687 is an FDA 510(k) clearance for the LifeWindow LW8 Lite. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Digicare Biomedical Technology, Inc. (Boynton Beach, US). The FDA issued a Cleared decision on September 25, 2019 after a review of 271 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Digicare Biomedical Technology, Inc. devices

FDA 510(k) Submission Details - K183687

510(k) Number K183687 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 28, 2018
Decision Date September 25, 2019
Days to Decision 271 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
146d slower than avg
Panel avg: 125d · This submission: 271d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 253
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K183687.
Eko Analysis Software
K192004 · Eko Devices, Inc. · Jan 2020
Masimo Rad-97 and Accessories
K191059 · Masimo Corporation · Dec 2019
T3 Platform software
K190273 · Etiometry, Inc. · Dec 2019
PeraMobile and PeraWatch
K183370 · Perahealth, Inc. · Sep 2019
B.O.L.T Base Unit, B.O.L.T Non-Invasive Blood Pressure (NIBP) Cuff, B.O.L.T Infared Radiation Energy Technology(IRT) Thermometer probe, B.O.L.T Pulse Oximeter(SPO2) probe, B.O.L.T Gluchobin Blood Glucose, Total Cholesterol and Hemoglobin meter
K182401 · Amzetta Technologies Private Limited · Aug 2019
DynoSense Vital Sign Measuring System
K190090 · Dynosense Corp. · Aug 2019